Skip to main content
OpenTrials
Completed

NCT Number: NCT02999282

Rehabilitative Trial for the Rescue of Neurophysiological Parameters in Progranulin Deficient Subjects

In this randomized, double-blind, sham-controlled study, the investigators will evaluate the effects of frontal and prefrontal anodal transcranial direct current stimulation (tDCS) on neurophysiological parameters of cortical connectivity, assessed by transcranial magnetic stimulation (TMS), in asymptomatic subjects bearing a pathogenic GRN mutation and in symptomatic patients with frontotemporal dementia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Frontotemporal Dementia Brain Diseases Central Nervous System Diseases Dementia Frontotemporal Lobar Degeneration GRN Related Frontotemporal Dementia Mental Disorders Metabolic Diseases Nervous System Diseases Neurocognitive Disorders Neurodegenerative Diseases Nutritional and Metabolic Diseases Proteostasis Deficiencies TDP-43 Proteinopathies

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Azienda Ospedaliera Spedali Civili di Brescia

Brescia, 25123, Italy

About this study

In this randomized, double-blind, sham-controlled study, the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation (tDCS) on neurophysiological parameters of cortical connectivity, assessed by transcranial magnetic stimulation (TMS), in asymptomatic subjects bearing a pathogenic GRN mutation and in symptomatic patients with frontotemporal dementia.

All patients will undergo genetic screening for progranulin mutations, a baseline neuropsychological and neurophysiological evaluation, including assessment of short interval intracortical inhibition, intracortical facilitation, short interval intracortical facilitation and long interval intracortical inhibition. Subjects will then be randomized in two groups, one receiving a 10 day (5 days/week for 2 weeks) treatment with anodal frontal and prefrontal anodal tDCS and the other receiving sham stimulation with identical parameters. After the intervention, patients will be reassessed with a neuropsychological and neurophysiological evaluation at 2 weeks, 1 month (only neurophysiological evaluation), 3 months and 6 month after treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

presymptomatic carriers, symptomatic genetic FTD patients, symptomatic sporadic FTD patients.

  • Presymptomatic carriers: defined as participants who are known carriers of a pathogenic mutation in the GRN gene, who do not fulfill current criteria for the behavioral variant FTD (bvFTD) (Rascovsky et al. 2011) or for the Primary Progressive Aphasias (PPA) (Gorno-Tempini et al. 2011). All subjects will be genotyped for known pathogenic mutations for FTD (GRN, C9orf72, MAPT, TDP-43) before participation.
  • Symptomatic genetic FTD: defined as patients who are known carriers of pathogenic mutation in the GRN gene, fulfilling current clinical criteria for behavioral variant FTD (bvFTD) (Rascovsky et al. 2011) or the agrammatic variant of Primary Progressive Aphasia (avPPA) (Gorno-Tempini et al. 2011).
  • Symptomatic sporadic FTD: defined as patients fulfilling current clinical criteria for behavioral variant FTD (bvFTD) (Rascovsky et al. 2011) or the agrammatic variant of Primary Progressive Aphasia (avPPA) (Gorno-Tempini et al. 2011), with a negative screening for pathogenic mutations in known FTD genes (GRN, C9orf72, MAPT, TDP-43). CSF analysis or amyloid PET imaging will be carried out to exclude focal variants of AD.

Exclusion criteria

  • Cerebrovascular disorders, previous stroke, hydrocephalus, and intra-cranial mass documented by MRI.
  • History of traumatic brain injury or other neurological diseases.
  • Serious medical illness other than FTD
  • History of seizures
  • Pregnancy
  • Metal implants in the head (except dental fillings)
  • Electronic implants (i.e. pace-maker, implanted medical pump)
  • Age <18 years

Treatment and study plan

anodal transcranial direct current stimulation

Device

10 sessions of anodal transcranial direct current stimulation (5 days/week for 2 weeks)

Sham Transcranial Direct Current Stimulation

Device

10 sessions of sham transcranial direct current stimulation (5 days/week for 2 weeks)

Primary outcomes

  1. Change in SICI measurements from Baseline

    Time frame: Baseline - 2 weeks

    By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on short interval intracortical inhibition (SICI)

  2. Change in ICF measurements from Baseline

    Time frame: Baseline - 2 weeks

    By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on intracortical facilitation (ICF).

Secondary outcomes

  1. Change in SICI measurements from Baseline

    Time frame: Baseline - 1 month - 3 months - 6 months

    By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on short interval intracortical inhibition (SICI)

  2. Change in ICF measurements from Baseline

    Time frame: Baseline - 1 month - 3 months - 6 months

    By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on intracortical facilitation (ICF).

  3. Change in LICI measurements from Baseline

    Time frame: Baseline - 1 month - 3 months - 6 months

    By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on long interval intracortical inhibition (LICI).

  4. Change in SICF measurements from Baseline

    Time frame: Baseline - 1 month - 3 months - 6 months

    By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of frontal and prefrontal anodal transcranial magnetic stimulation on short interval intracortical facilitation (SICF).

  5. Change in MMSE scores from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    The Mini Mental State Examination (MMMSE) is a 30-point questionnaire that is used to measure cognitive impairment.

  6. Change in phonemic fluencies scores from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    Produce as many words as possible beginning with a specified letter in 60 seconds

  7. Change in semantic fluencies scores from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    Produce as many words as possible from a category in 60 seconds

  8. Change in digit span forward scores from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    Participants hear a sequence of numerical digits and are tasked to recall the sequence correctly, with increasingly longer sequences being tested in each trial. The participant's span is the longest number of sequential digits that can accurately be remembered.

  9. Change in digit span backward scores from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    Participants hear a sequence of numerical digits and are tasked to recall the sequence correctly in reverse order, with increasingly longer sequences being tested in each trial. The participant's span is the longest number of sequential digits that can accurately be remembered.

  10. Change in camel and cactus test scores from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    Evaluates associative semantic memory with 64 items presented for naming and word-picture matching.

  11. Change in TMTA scores from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    The task requires a subject to connect a sequence of 25 consecutive targets on a sheet of paper to examine cognitive processing speed.

  12. Change in TMTB scores from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    The task requires a subject to connect a sequence of 25 consecutive targets on a sheet of paper, alternating between numbers and letters, to examine executive functioning.

  13. Change in Stroop test scores from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    Measure a person's selective attention capacity and skills, as well as their processing speed ability.

  14. Change in Symbol Digit test scores from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    It consists of digit-symbol pairs followed by a list of digits. Under each digit the subject should write down the corresponding symbol as fast as possible. The number of correct symbols within the allowed time is measured.

  15. Change in Block Design test scores from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    To evaluated spatial visualization ability and motor skills. The test-taker uses hand movements to rearrange blocks that have various color patterns on different sides to match a pattern. The items in a block design test are scored both by accuracy in matching the pattern and by speed in completing each item.

  16. Change in The modified EkmanFaces Test from Baseline

    Time frame: Baseline - 2 weeks - 3 months - 6 months

    Each face is presented on a sheet with six labels of basic emotions below the photograph. The patient was required to respond verbally, deciding the label that best described the facial expression shown.

Sponsors and collaborators

Lead sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Other

Registry information

Official study title

Rehabilitative Trial for the Recovery of Neurophysiological Parameters in Progranulin Mutation Carriers Through the Use of Transcranial Direct Current Stimulation (tDCS)

Acronym: ReRescuePGR

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
Dec 21, 2016
Registry last updated
Mar 3, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.